Pfizer/BMS blood thinner gains new licence
August 22, 2014Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin
Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …
AstraZeneca shores up defences against Pfizer
August 22, 2014Medical Communications, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, deal, merger
AstraZeneca has been making a series of big deals over the past three months as it looks to close the …
ELC Group names new senior head
August 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Siddharth Chachad, elf group
UK regulatory affairs provider the ELC Group has confirmed the appointment of clinical pharmacologist Dr Siddharth Chachad as its head …
Wellcome Trust makes Ebola research investment
August 21, 2014Research and Development, Sales and Marketing Africa, Ebola, Nigeria, deltas, welcome trust
The Wellcome Trust is launching a new multimillion pound initiative for emergency Ebola research coupled with a £40 million investment …
Celebrity-endorsed drug ads don’t work, says research
August 21, 2014Medical Communications, Sales and Marketing advertising, bon jovi, dtc, healthcare marketing, paula deen, pharma
New research reveals the US system of using celebrity-endorsed drug adverts offer treatments more credibility but not influence when it …
Masters Speciality Pharma hires head from Idis
August 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing masters speciality pharma, warren crawford
Masters Speciality Pharma has appointed Warren Crawford as a partner development director to lead and implement creative deal structures for …
GPs admit to wrongly prescribing antibiotics
August 20, 2014Medical Communications, Sales and Marketing GPs, UK, doctors, longitude, prescribing, prize
Nearly half of British GPs surveyed have admitted to prescribing antibiotics unnecessarily due to uncertainty and a lack of diagnostic …
AZ and Mitsubishi partner on diabetic nephropathy
August 20, 2014Research and Development, Sales and Marketing AstraZeneca, BMS, Mitsubishi, cvmd, diabetes, nephropathy
AstraZeneca and Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a new three-year research deal in the area of …
FDA approves Sanofi’s new rare disease drug
August 20, 2014Research and Development, Sales and Marketing Elelyso, Gaucher disease, Genzyme, Sanofi, eliglustat
Sanofi’s biologics unit Genzyme has been granted approval for a new drug to treat the rare genetic disorder Gaucher’s disease. …
New chief executive for Rabin Martin
August 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing jeffrey sturchio, rabin martin
US health consulting firm Rabin Martin has appointed Dr Jeffrey Sturchio as its new president and chief executive. Sturchio joined …
Reprieve for AstraZeneca as US drops drug investigation
August 19, 2014Sales and Marketing AstraZeneca, Brilinta, US, blood, justice, plato
The US Justice Department has pulled a controversial investigation into AstraZeneca’s pivotal clinical trial after finding no wrongdoing. The inquiry …
Sanofi and PATH launch large-scale malaria drug production
August 19, 2014Manufacturing and Production, Sales and Marketing Africa, Sanofi, acts, artemisinin, malaria, path
Sanofi and global health charity PATH have come together to launch a large-scale production line of malaria jab semisynthetic artemisinin …
New chief medical officer for TeamHealth
August 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing miles, snowden, teamhealth
Outsourced doctor staffing US firm TeamHealth Holdings has appointed Dr Miles Snowden as the company’s chief medical officer (CMO). Snowden …
Science will ‘lose out’ if Scotland chooses independence
August 18, 2014Research and Development, Sales and Marketing Conservative, Scotland, UK, george freeman, life sciences
The new minister for UK life sciences George Freeman has warned that independence from England “would damage Scotland’s edge in …
Top four cancer killer rates ‘fall by a third’
August 18, 2014Research and Development, Sales and Marketing CRUK, Cancer, bowel, charity, lung, prostate, research
Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …
FDA approves Biogen’s long-acting MS drug
August 18, 2014Sales and Marketing Avonex, Biogen, FDA, MS, Rebif, plegridy, tecfidera
Biogen Idec has racked up another approval over the weekend after its latest multiple sclerosis treatment Plegridy gained FDA backing. …
The end of salesmanship?
August 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Rose, a bpi, all trials, evidence, gold acre, sales, salesmanship
Although my specialism for the last 35 years has been clinical research, I actually started in the pharmaceutical industry as …
Oxford BioMedica takes on executive position
August 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioMedica, blake
Gene and cell therapy firm Oxford BioMedica has confirmed that non-executive director Dr Paul Blake has been appointed to the …
Charities ‘disappointed’ in NICE and Janssen
August 15, 2014Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, prostate
The Institute of Cancer Research and Prostate Cancer UK are both urging NICE and Janssen to ‘get their act together’ …
Life hires principal writer from PAN
August 15, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Catriona Hampton, Life, Pan
Catriona Hampton has joined Life Healthcare Communications in Windsor, UK as a principal writer. Hampton who graduated in Immunology at …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
